Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
57,270,400
-
Share change
-
+637,875
-
Total reported value
-
$4,709,749,015
-
Put/Call ratio
-
67%
-
Price per share
-
$82.22
-
Number of holders
-
243
-
Value change
-
-$96,675,294
-
Number of buys
-
149
-
Number of sells
-
127
Institutional Holders of MIRATI THERAPEUTICS INC - COM (MRTX) as of Q1 2022
As of 31 Mar 2022,
MIRATI THERAPEUTICS INC - COM (MRTX) was held by
243 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,270,400 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, VANGUARD GROUP INC, Aviva Holdings Ltd., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, FMR LLC, BOXER CAPITAL, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and ORBIMED ADVISORS LLC.
This page lists
243
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.